ENTRY       D05375                      Drug
NAME        Paroxetine mesylate (USAN);
            Brisdelle (TN);
            Pexeva (TN)
PRODUCT     PEXEVA (Sebela Pharmaceuticals)
  GENERIC   PAROXETINE (Padagis US LLC)
            PAROXETINE (Solco Healthcare LLC)
FORMULA     C19H20FNO3. CH4SO3
EXACT_MASS  425.1308
MOL_WEIGHT  425.4711
CLASS       Neuropsychiatric agent
             DG01659  Selective serotonin reuptake inhibitor (SSRI)
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
            Metabolizing enzyme inhibitor
             DG01645  CYP2D6 inhibitor
REMARK      ATC code: N06AB05
            Chemical structure group: DG00944
            Product (DG00944): D02260<JP/US> D05374<US> D05375<US>
EFFICACY    Antidepressant, Selective serotonin reuptake inhibitor (SSRI)
  DISEASE   Major depressive disorder [DS:H01646]
            Obsessive compulsive disorder [DS:H01450]
            Panic disorder [DS:H01664]
            Generalized anxiety disorder [DS:H01662]
COMMENT     Fluoxetine derivative
TARGET      SLC6A4 (HTT) [HSA:6532] [KO:K05037]
  PATHWAY   hsa04726(6532)  Serotonergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION CYP inhibition: CYP2D6 [HSA:1565]
STR_MAP     map07027  Antidepressants
            map07234  Neurotransmitter transporter inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AB Selective serotonin reuptake inhibitors
                 N06AB05 Paroxetine
                  D05375  Paroxetine mesylate (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antidepressants
              SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
               Paroxetine
                D05375  Paroxetine mesylate (USAN)
             Anxiolytics
              SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
               Paroxetine
                D05375  Paroxetine mesylate (USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01659  Selective serotonin reuptake inhibitor (SSRI)
               DG00944  Paroxetine
                D05375  Paroxetine mesylate
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00944  Paroxetine
                D05375  Paroxetine mesylate
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00944  Paroxetine
                D05375  Paroxetine mesylate
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG01659  Selective serotonin reuptake inhibitor (SSRI)
               D05375  Paroxetine mesylate
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A4 (HTT)
                 D05375  Paroxetine mesylate (USAN) &lt;US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D05375
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D05375
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01659  Selective serotonin reuptake inhibitor (SSRI)
               DG00944  Paroxetine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00944  Paroxetine
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00944  Paroxetine
DBLINKS     CAS: 217797-14-3
            PubChem: 47207051
            LigandBox: D05375
ATOM        29
            1   C1y C    10.4825   -8.1745
            2   C1y C     9.2690   -8.8721
            3   C8y C    10.4883   -6.8611
            4   C1x C    11.6958   -8.8721
            5   C1b C     8.0556   -8.1745
            6   C1x C     9.2690  -10.2791
            7   C8x C    11.7018   -6.1634
            8   C8x C     9.2748   -6.1634
            9   C1x C    11.6958  -10.2791
            10  O2a O     6.8361   -8.8721
            11  N1x N    10.4825  -10.9766
            12  C8x C    11.7018   -4.7624
            13  C8x C     9.2748   -4.7566
            14  C8y C     5.6226   -8.1686
            15  C8y C    10.4883   -4.0589
            16  C8x C     5.6286   -6.7733
            17  C8x C     4.4151   -8.8781
            18  X   F    10.4942   -2.7982
            19  C8y C     4.4208   -6.0699
            20  C8x C     3.2016   -8.1745
            21  C8y C     3.2016   -6.7733
            22  O2x O     4.1337   -4.6456
            23  O2x O     2.2048   -5.7829
            24  C1x C     2.6857   -4.3996
            25  O1d O    15.9383   -6.5271
            26  S4a S    15.9383   -7.9217
            27  C1a C    14.5438   -7.9217
            28  O1d O    17.3329   -7.9217
            29  O1d O    15.9383   -9.3162
BOND        31
            1     1   2 1
            2     1   3 1 #Down
            3     1   4 1
            4     2   5 1 #Up
            5     2   6 1
            6     3   7 2
            7     3   8 1
            8     4   9 1
            9     5  10 1
            10    6  11 1
            11    7  12 1
            12    8  13 2
            13   10  14 1
            14   12  15 2
            15   14  16 2
            16   14  17 1
            17   15  18 1
            18   16  19 1
            19   17  20 2
            20   19  21 2
            21   19  22 1
            22   21  23 1
            23   22  24 1
            24    9  11 1
            25   13  15 1
            26   20  21 1
            27   23  24 1
            28   25  26 2
            29   26  27 1
            30   26  28 1
            31   26  29 2
///
